January 22, 2018 / 1:46 AM / 4 months ago

Sanofi near deal to buy Bioverativ for more than $11.5 bln -WSJ

Jan 21 (Reuters) - Sanofi SA is said to be near a deal to buy drug maker Bioverativ Inc for more than $11.5 billion, the Wall Street Journal reported, citing people familiar with the matter.

The deal, which could be announced as soon as Monday, would value Bioverativ at about $105 a share, the Journal reported. (on.wsj.com/2mYJulp) Sanofi and Bioverativ were not immediately available for comment outside regular business hours.

Reporting by Shubham Kalia in Bengaluru; Editing by Paul Simao

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below